Advertisement

Adolescent Female Assent in Clinical Trials: A Model Assent Process

  • Debra Mattison
  • Terry M. VandenBosch
  • Errol Soskolne
  • Becky Ward
Article

Abstract

Multiple issues concerning the assent process for adolescent female participation in clinical trials are present in a process that has historically been based on an adult developmental and cognitive perspective. Adolescents are experiencing physiological and psycho-social, sexual growth and, therefore, should not be approached as though they are adults. This paper addresses important assent elements from the unique developmental perspective of female adolescents including sexual activity, birth control, privacy rights, confidentiality, and pregnancy. A proposed assent process and model assent form addressing these important issues are presented.

Key Words

Female adolescents Clinical trials Assent 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    National Institutes of Health. Policy and Guidelines on the Inclusion of children as Participants in Research Involving Human Subjects. Bethesda, MD: National Institutes of Health; 1998.Google Scholar
  2. 2.
    Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients. Rockville, MD: Food and Drug Administration; 1997.Google Scholar
  3. 3.
    Food and Drug Administration. Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients: Final Rule. Federal Register. 1998;63(December 2):66631–66672.Google Scholar
  4. 4.
    VandenBosch TV, Ward BG, Mattison D. A reappraisal of female adolescent participation in drug clinical trials. IRB. 1999;21(1):1–5.CrossRefGoogle Scholar
  5. 5.
    Koren G, Carmeli DB, Carmeli YS, Haslam R. Maturity of children to consent to medical research: The babysitter test. J Med Ethics. 1993;19(3):142–147.CrossRefGoogle Scholar
  6. 6.
    Nicholson RH. Medical Research with Children: Ethics, Law and Practice. Oxford: Oxford University Press, 1986.Google Scholar
  7. 7.
    Leikin SL. Minor’s assent or dissent to medical treatment. J Pediatrics. 1983;102(2):169–176.CrossRefGoogle Scholar
  8. 8.
    Bookeloo BO, Schamus LA, Cheng TL, Simmens SJ. Young adolescents’ comfort with discussion about sexual problems with their physician. Arch Pediatric Adolescent Med. 1996;150:1146–1152.CrossRefGoogle Scholar
  9. 9.
    Cheng TL, Savageau JA, Sattler AL, Dewitt, TG. Confidentiality in health care: A survey of knowledge, perceptions and attitudes among high school students. JAMA. 1993;269(11):1404–1407.CrossRefGoogle Scholar
  10. 10.
    Alan Guttmacher Institute. Sex and America’s Teenagers. New York: Alan Guttmacher Institute; 1994.Google Scholar
  11. 11.
    Thompson S. Putting a big thing into a little hole: Teenage girls’ accounts of sexual initiation. J Sex Research. 1990;27(3):341–361.CrossRefGoogle Scholar
  12. 12.
    Trussell J, Card JJ, Hogue CJ. Adolescent Sexual Behavior, Pregnancy and Childbearing. In Hatcher RA, Trussell J, Stewart F, Cates W, Setward GK, Guest F, Kowal D. Contraceptive Technology. 17th ed. New York: Ardent Media, Inc.; 1998.Google Scholar
  13. 13.
    Hawke JM, Jainchill N, DeLeon G. The prevalence of sexual abuse and its impact on the onset of drug use among adolescents in therapeutic community drug treatment. J Child Adolescent Substance Abuse. 2000;9(3):35–49.CrossRefGoogle Scholar
  14. 14.
    Gilligan C. In a Different Voice: Psychological Theory and Women’s Development. Cambridge, MA: Harvard University Press; 1993.Google Scholar
  15. 15.
    Warren CW, Santelli JS, Everette SA, Kann L, Collins JL, Cassell C, Morris L, Kolbe LJ. Sexual behavior among U.S. high school students, 1990–1995. Family Planning Perspectives. 1998;30(4):170–172; 200.CrossRefGoogle Scholar
  16. 16.
    Food and Drug Administration. FDA Information Sheets. Evaluation of Gender Differences in Clinical Investigations. Rockville, MD: Food and Drug Administration; 1995;71.Google Scholar
  17. 17.
    Connor J. Sexually transmitted diseases among teenagers in England and Wales. Communicable Disease Report. CDR Review. 1997;7(12):R173–178.PubMedGoogle Scholar
  18. 18.
    Krowchuk DP. Sexually transmitted diseases in adolescents: An update. Comprehensive Therapy. 1999;25(5):265–271.CrossRefGoogle Scholar
  19. 19.
    Rogers AS, D’Angelo L, Futterman D. Guidelines for adolescent participation in research: Current realities and possible resolutions. IRB. 1994;16(4):1–5.CrossRefGoogle Scholar
  20. 20.
    Santelli JS, Rosenfeld WD, DuRant RH, Dubler N, Morreale M, English A, Rogers AS. Guidelines for adolescent health research: A position paper of the Society for Adolescent Medicine. J Adolescent Health. 1995;17(5):270–276.CrossRefGoogle Scholar
  21. 21.
    Humphey GB, Boon CM, van Linden van den Heuvell GF, van de wiel HB. The occurrence of high levels of acute behavioral distress in children and adolescents undergoing routine venipunctures. Pediatrics. 1992;90(1):87–91.Google Scholar
  22. 22.
    Fassler D. The aetiology and treatment of needle phobia in the young patient—A review. Am J Ortho-psychiatry. 1985;55(3):371–377.Google Scholar

Copyright information

© Drug Information Association, Inc 2002

Authors and Affiliations

  • Debra Mattison
    • 1
  • Terry M. VandenBosch
    • 1
  • Errol Soskolne
    • 1
  • Becky Ward
    • 1
  1. 1.Department of Social WorkSt. Joseph Mercy HospitalAnn ArborUSA

Personalised recommendations